# Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus

> **NCT03867500** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Obesity

## Interventions

- **DRUG:** Niacin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03867500
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2021-12-22
- **Final completion:** 2021-12-22
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03867500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03867500, "Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT03867500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*